Approval · Notice of Compliance 18685 · 2016
MOVAPO: Notice of Compliance 18685
Issued November 22, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18685
- Date
- November 22, 2016
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
Medicinal ingredients
- APOMORPHINE HCL 30 MG per PEN
- APOMORPHINE HCL 20 MG per AMP